Frequencies for first 10,000 rows of indi_pt variable in indi2007q2 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMEN SCAN | 1 0.01 0.01 ABDOMINAL PAIN | 12 0.12 0.13 ABNORMAL BEHAVIOUR | 4 0.04 0.17 ABORTION SPONTANEOUS | 2 0.02 0.19 ABSCESS | 1 0.01 0.20 ACARODERMATITIS | 2 0.02 0.22 ACNE | 38 0.38 0.60 ACNE CYSTIC | 2 0.02 0.62 ACQUIRED IMMUNODEFICIENCY SYNDROME | 29 0.29 0.91 ACROMEGALY | 2 0.02 0.93 ACUTE CORONARY SYNDROME | 3 0.03 0.96 ACUTE ENDOCARDITIS | 3 0.03 0.99 ACUTE HIV INFECTION | 1 0.01 1.00 ACUTE LEUKAEMIA | 4 0.04 1.04 ACUTE LYMPHOCYTIC LEUKAEMIA | 25 0.25 1.29 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT | 1 0.01 1.30 ACUTE MYELOID LEUKAEMIA | 35 0.35 1.65 ACUTE MYELOID LEUKAEMIA RECURRENT | 12 0.12 1.77 ACUTE MYOCARDIAL INFARCTION | 3 0.03 1.80 ACUTE PROMYELOCYTIC LEUKAEMIA | 7 0.07 1.87 ACUTE SINUSITIS | 2 0.02 1.89 ADENOCARCINOMA | 2 0.02 1.91 ADENOSINE DEAMINASE DEFICIENCY | 1 0.01 1.92 ADENOVIRUS INFECTION | 1 0.01 1.93 ADRENAL CARCINOMA | 1 0.01 1.94 ADRENAL DISORDER | 1 0.01 1.95 ADRENAL INSUFFICIENCY | 2 0.02 1.97 ADVERSE DRUG REACTION | 1 0.01 1.98 AFFECTIVE DISORDER | 7 0.07 2.05 AGGRESSION | 4 0.04 2.09 AGITATION | 11 0.11 2.20 ALCOHOL USE | 2 0.02 2.22 ALLERGIC GRANULOMATOUS ANGIITIS | 2 0.02 2.24 ALLERGY TO ARTHROPOD STING | 2 0.02 2.26 ALLOGENIC BONE MARROW TRANSPLANTATION.. | 3 0.03 2.29 ALOPECIA | 2 0.02 2.31 AMENORRHOEA | 2 0.02 2.33 AMNESIA | 1 0.01 2.34 AMYLOIDOSIS | 2 0.02 2.36 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 2.37 ANAEMIA | 16 0.16 2.53 ANAEMIA HAEMOLYTIC AUTOIMMUNE | 1 0.01 2.54 ANAEMIA OF MALIGNANT DISEASE | 5 0.05 2.59 ANAESTHESIA | 5 0.05 2.64 ANAL ULCER | 2 0.02 2.66 ANALGESIC EFFECT | 7 0.07 2.73 ANALGESIC THERAPY | 7 0.07 2.80 ANAPLASTIC ASTROCYTOMA | 2 0.02 2.82 ANGINA PECTORIS | 26 0.26 3.08 ANGIOEDEMA | 1 0.01 3.09 ANGIOGRAM | 1 0.01 3.10 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA | 5 0.05 3.15 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA RE.. | 1 0.01 3.16 ANGIOPLASTY | 1 0.01 3.17 ANKLE FRACTURE | 1 0.01 3.18 ANKYLOSING SPONDYLITIS | 24 0.24 3.42 ANOREXIA | 3 0.03 3.45 ANTIALLERGIC THERAPY | 1 0.01 3.46 ANTIBIOTIC PROPHYLAXIS | 9 0.09 3.55 ANTICOAGULANT THERAPY | 12 0.12 3.67 ANTIDEPRESSANT THERAPY | 5 0.05 3.72 ANTIDIARRHOEAL SUPPORTIVE CARE | 1 0.01 3.73 ANTIFUNGAL PROPHYLAXIS | 37 0.37 4.10 ANTIINFLAMMATORY THERAPY | 2 0.02 4.12 ANTIPLATELET THERAPY | 2 0.02 4.14 ANTIPYRESIS | 1 0.01 4.15 ANTIVIRAL PROPHYLAXIS | 3 0.03 4.18 ANXIETY | 85 0.85 5.03 ANXIETY DISORDER | 4 0.04 5.07 AORTIC VALVE REPLACEMENT | 1 0.01 5.08 APLASTIC ANAEMIA | 1 0.01 5.09 APPENDICEAL ABSCESS | 1 0.01 5.10 ARRHYTHMIA | 11 0.11 5.21 ARTERIAL OCCLUSIVE DISEASE | 1 0.01 5.22 ARTERIOGRAM | 2 0.02 5.24 ARTERIOSCLEROSIS | 1 0.01 5.25 ARTERIOSCLEROSIS CORONARY ARTERY | 5 0.05 5.30 ARTERIOSCLEROSIS OBLITERANS | 1 0.01 5.31 ARTERIOVENOUS FISTULA SITE COMPLICATION | 1 0.01 5.32 ARTHRALGIA | 39 0.39 5.71 ARTHRITIS | 117 1.17 6.88 ARTHRITIS INFECTIVE | 2 0.02 6.90 ARTHROPATHY | 3 0.03 6.93 ARTIFICIAL CROWN PROCEDURE | 1 0.01 6.94 ASCITES | 5 0.05 6.99 ASPERGILLOSIS | 2 0.02 7.01 ASSISTED DELIVERY | 1 0.01 7.02 ASTHENIA | 2 0.02 7.04 ASTHMA | 102 1.02 8.06 ATRIAL FIBRILLATION | 55 0.55 8.61 ATRIAL FLUTTER | 2 0.02 8.63 ATROPHIC VULVOVAGINITIS | 4 0.04 8.67 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 49 0.49 9.16 AUTOIMMUNE DISORDER | 1 0.01 9.17 AUTOIMMUNE THYROIDITIS | 1 0.01 9.18 B-CELL LYMPHOMA | 22 0.22 9.40 BACK PAIN | 55 0.55 9.95 BACTERAEMIA | 2 0.02 9.97 BACTERIAL INFECTION | 2 0.02 9.99 BARRETT'S OESOPHAGUS | 1 0.01 10.00 BASEDOW'S DISEASE | 1 0.01 10.01 BEHCET'S SYNDROME | 7 0.07 10.08 BENIGN HYDATIDIFORM MOLE | 1 0.01 10.09 BENIGN PROSTATIC HYPERPLASIA | 22 0.22 10.31 BICUSPID AORTIC VALVE | 1 0.01 10.32 BILE DUCT CANCER | 1 0.01 10.33 BILE DUCT CANCER STAGE IV | 2 0.02 10.35 BILIARY TRACT DISORDER | 2 0.02 10.37 BIOPSY CERVIX | 1 0.01 10.38 BIPOLAR DISORDER | 86 0.86 11.24 BIPOLAR I DISORDER | 3 0.03 11.27 BIPOLAR II DISORDER | 1 0.01 11.28 BLADDER CANCER | 9 0.09 11.37 BLADDER CANCER RECURRENT | 1 0.01 11.38 BLADDER TRANSITIONAL CELL CARCINOMA | 1 0.01 11.39 BLOOD CHOLESTEROL | 13 0.13 11.52 BLOOD CHOLESTEROL ABNORMAL | 2 0.02 11.54 BLOOD CHOLESTEROL INCREASED | 37 0.37 11.91 BLOOD CORTICOTROPHIN ABNORMAL | 1 0.01 11.92 BLOOD DISORDER | 2 0.02 11.94 BLOOD FOLLICLE STIMULATING HORMONE AB.. | 1 0.01 11.95 BLOOD GLUCOSE FLUCTUATION | 1 0.01 11.96 BLOOD GLUCOSE INCREASED | 1 0.01 11.97 BLOOD IRON DECREASED | 1 0.01 11.98 BLOOD PHOSPHORUS INCREASED | 1 0.01 11.99 BLOOD POTASSIUM DECREASED | 1 0.01 12.00 BLOOD PRESSURE | 20 0.20 12.20 BLOOD PRESSURE ABNORMAL | 2 0.02 12.22 BLOOD PRESSURE DECREASED | 3 0.03 12.25 BLOOD PRESSURE INCREASED | 5 0.05 12.30 BLOOD TESTOSTERONE DECREASED | 1 0.01 12.31 BLOOD TRIGLYCERIDES INCREASED | 2 0.02 12.33 BLOOD URIC ACID INCREASED | 1 0.01 12.34 BODY HEIGHT BELOW NORMAL | 1 0.01 12.35 BONE DISORDER | 1 0.01 12.36 BONE LESION | 2 0.02 12.38 BONE MARROW DISORDER | 2 0.02 12.40 BONE MARROW TRANSPLANT | 9 0.09 12.49 BONE NEOPLASM | 1 0.01 12.50 BONE PAIN | 4 0.04 12.54 BONE SARCOMA | 4 0.04 12.58 BONE SCAN | 3 0.03 12.61 BORRELIA BURGDORFERI SEROLOGY POSITIVE | 2 0.02 12.63 BRADYCARDIA | 2 0.02 12.65 BRAIN MASS | 3 0.03 12.68 BRAIN NEOPLASM | 4 0.04 12.72 BRAIN OEDEMA | 1 0.01 12.73 BRAIN STEM HAEMORRHAGE | 2 0.02 12.75 BREAKTHROUGH PAIN | 8 0.08 12.83 BREAST CANCER | 101 1.01 13.84 BREAST CANCER FEMALE | 13 0.13 13.97 BREAST CANCER METASTATIC | 56 0.56 14.53 BREAST CANCER RECURRENT | 1 0.01 14.54 BREAST CANCER STAGE II | 4 0.04 14.58 BREAST CANCER STAGE III | 1 0.01 14.59 BRONCHIECTASIS | 1 0.01 14.60 BRONCHITIS | 28 0.28 14.88 BRONCHITIS CHRONIC | 2 0.02 14.90 BRONCHOPNEUMONIA | 7 0.07 14.97 BRONCHOPNEUMOPATHY | 3 0.03 15.00 BRONCHOPULMONARY ASPERGILLOSIS | 8 0.08 15.08 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC | 1 0.01 15.09 BURKITT'S LYMPHOMA | 13 0.13 15.22 BURNING SENSATION | 1 0.01 15.23 BURSITIS | 2 0.02 15.25 C-REACTIVE PROTEIN INCREASED | 1 0.01 15.26 CACHEXIA | 1 0.01 15.27 CAESAREAN SECTION | 2 0.02 15.29 CANCER PAIN | 12 0.12 15.41 CANDIDIASIS | 10 0.10 15.51 CARCINOID SYNDROME | 2 0.02 15.53 CARCINOID TUMOUR | 1 0.01 15.54 CARCINOMA IN SITU OF BLADDER | 1 0.01 15.55 CARDIAC DISORDER | 11 0.11 15.66 CARDIAC FAILURE | 28 0.28 15.94 CARDIAC FAILURE CHRONIC | 3 0.03 15.97 CARDIAC FAILURE CONGESTIVE | 6 0.06 16.03 CARDIAC STRESS TEST | 1 0.01 16.04 CARDIOMYOPATHY | 4 0.04 16.08 CARDIOVASCULAR DISORDER | 9 0.09 16.17 CARDIOVASCULAR EVENT PROPHYLAXIS | 4 0.04 16.21 CAROTID ARTERY OCCLUSION | 2 0.02 16.23 CAROTID ARTERY STENOSIS | 1 0.01 16.24 CATAPLEXY | 1 0.01 16.25 CATARACT | 1 0.01 16.26 CATHETER SEPSIS | 1 0.01 16.27 CATHETERISATION CARDIAC | 1 0.01 16.28 CELLULITIS | 2 0.02 16.30 CELLULITIS ORBITAL | 1 0.01 16.31 CENTRAL PAIN SYNDROME | 1 0.01 16.32 CEREBRAL ARTERIOSCLEROSIS | 1 0.01 16.33 CEREBRAL ARTERY EMBOLISM | 1 0.01 16.34 CEREBRAL INFARCTION | 10 0.10 16.44 CEREBRAL ISCHAEMIA | 1 0.01 16.45 CEREBRAL PALSY | 3 0.03 16.48 CEREBRAL TOXOPLASMOSIS | 2 0.02 16.50 CEREBROVASCULAR ACCIDENT | 3 0.03 16.53 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 17 0.17 16.70 CEREBROVASCULAR DISORDER | 1 0.01 16.71 CERUMEN REMOVAL | 1 0.01 16.72 CERVIX CARCINOMA | 5 0.05 16.77 CHEILITIS | 1 0.01 16.78 CHEMOTHERAPY | 16 0.16 16.94 CHEST PAIN | 5 0.05 16.99 CHOLANGITIS | 1 0.01 17.00 CHOLELITHIASIS | 2 0.02 17.02 CHOLESTASIS | 1 0.01 17.03 CHONDROSARCOMA METASTATIC | 1 0.01 17.04 CHOREA | 3 0.03 17.07 CHOROIDAL NEOVASCULARISATION | 1 0.01 17.08 CHRONIC LYMPHOCYTIC LEUKAEMIA | 7 0.07 17.15 CHRONIC MYELOID LEUKAEMIA | 15 0.15 17.30 CHRONIC MYELOMONOCYTIC LEUKAEMIA | 1 0.01 17.31 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 33 0.33 17.64 CHYLOTHORAX | 1 0.01 17.65 COAGULOPATHY | 2 0.02 17.67 COGNITIVE DISORDER | 1 0.01 17.68 COLITIS | 4 0.04 17.72 COLITIS ULCERATIVE | 27 0.27 17.99 COLON CANCER | 30 0.30 18.29 COLON CANCER METASTATIC | 22 0.22 18.51 COLON CANCER STAGE III | 3 0.03 18.54 COLONOSCOPY | 4 0.04 18.58 COLONY STIMULATING FACTOR PROPHYLAXIS | 1 0.01 18.59 COLORECTAL CANCER | 35 0.35 18.94 COLORECTAL CANCER METASTATIC | 27 0.27 19.21 COLOSTOMY | 1 0.01 19.22 COMPLEX REGIONAL PAIN SYNDROME | 3 0.03 19.25 COMPUTERISED TOMOGRAM | 4 0.04 19.29 COMPUTERISED TOMOGRAM ABDOMEN | 5 0.05 19.34 CONFUSIONAL STATE | 1 0.01 19.35 CONNECTIVE TISSUE DISORDER | 1 0.01 19.36 CONSTIPATION | 52 0.52 19.88 CONSTIPATION PROPHYLAXIS | 3 0.03 19.91 CONTRACEPTION | 46 0.46 20.37 CONVULSION | 32 0.32 20.69 CONVULSION PROPHYLAXIS | 2 0.02 20.71 COORDINATION ABNORMAL | 1 0.01 20.72 CORD BLOOD TRANSPLANT THERAPY | 1 0.01 20.73 CORNEAL TRANSPLANT | 1 0.01 20.74 CORONARY ARTERY BYPASS | 4 0.04 20.78 CORONARY ARTERY DILATATION | 1 0.01 20.79 CORONARY ARTERY DISEASE | 13 0.13 20.92 CORONARY ARTERY INSUFFICIENCY | 1 0.01 20.93 COUGH | 15 0.15 21.08 CROHN'S DISEASE | 55 0.55 21.63 CRYPTOCOCCOSIS | 1 0.01 21.64 CUTANEOUS LUPUS ERYTHEMATOSUS | 1 0.01 21.65 CYCLOTHYMIC DISORDER | 1 0.01 21.66 CYSTIC FIBROSIS | 1 0.01 21.67 CYSTINOSIS | 2 0.02 21.69 CYSTITIS | 3 0.03 21.72 CYTOGENETIC ANALYSIS ABNORMAL | 1 0.01 21.73 CYTOMEGALOVIRUS CHORIORETINITIS | 3 0.03 21.76 CYTOMEGALOVIRUS ENTEROCOLITIS | 2 0.02 21.78 CYTOMEGALOVIRUS INFECTION | 4 0.04 21.82 CYTOMEGALOVIRUS TEST | 1 0.01 21.83 CYTOMEGALOVIRUS VIRAEMIA | 1 0.01 21.84 DANDRUFF | 1 0.01 21.85 DECREASED ACTIVITY | 1 0.01 21.86 DECREASED APPETITE | 1 0.01 21.87 DECUBITUS ULCER | 5 0.05 21.92 DEEP VEIN THROMBOSIS | 5 0.05 21.97 DELIRIUM | 3 0.03 22.00 DELUSION | 1 0.01 22.01 DELUSIONAL DISORDER, PERSECUTORY TYPE | 1 0.01 22.02 DEMENTIA | 9 0.09 22.11 DEMENTIA ALZHEIMER'S TYPE | 27 0.27 22.38 DENTAL CLEANING | 1 0.01 22.39 DENTAL DISORDER PROPHYLAXIS | 3 0.03 22.42 DENTAL OPERATION | 2 0.02 22.44 DEPRESSED LEVEL OF CONSCIOUSNESS | 1 0.01 22.45 DEPRESSION | 265 2.65 25.10 DEPRESSIVE SYMPTOM | 2 0.02 25.12 DERMATITIS ALLERGIC | 1 0.01 25.13 DERMATITIS ATOPIC | 2 0.02 25.15 DERMATITIS CONTACT | 1 0.01 25.16 DERMATOMYOSITIS | 4 0.04 25.20 DIABETES MELLITUS | 158 1.58 26.78 DIABETES MELLITUS INSULIN-DEPENDENT | 21 0.21 26.99 DIABETES MELLITUS NON-INSULIN-DEPENDENT | 53 0.53 27.52 DIABETIC NEPHROPATHY | 1 0.01 27.53 DIABETIC NEUROPATHY | 8 0.08 27.61 DIABETIC RETINOPATHY | 1 0.01 27.62 DIAGNOSTIC PROCEDURE | 2 0.02 27.64 DIALYSIS | 4 0.04 27.68 DIARRHOEA | 16 0.16 27.84 DIFFUSE LARGE B-CELL LYMPHOMA | 3 0.03 27.87 DIPLOPIA | 1 0.01 27.88 DISCOMFORT | 1 0.01 27.89 DISSOCIATIVE DISORDER | 1 0.01 27.90 DISTURBANCE IN ATTENTION | 1 0.01 27.91 DIURETIC THERAPY | 2 0.02 27.93 DIZZINESS | 3 0.03 27.96 DRUG ABUSER | 9 0.09 28.05 DRUG DEPENDENCE | 4 0.04 28.09 DRUG ERUPTION | 3 0.03 28.12 DRUG EXPOSURE DURING PREGNANCY | 23 0.23 28.35 DRUG EXPOSURE VIA BREAST MILK | 2 0.02 28.37 DRUG HYPERSENSITIVITY | 1 0.01 28.38 DRUG INEFFECTIVE FOR UNAPPROVED INDIC.. | 1 0.01 28.39 DRUG THERAPY | 4 0.04 28.43 DRUG USE FOR UNKNOWN INDICATION | 1,275 12.75 41.18 DRUG WITHDRAWAL SYNDROME | 1 0.01 41.19 DRY EYE | 2 0.02 41.21 DRY SKIN | 2 0.02 41.23 DUODENAL ULCER | 2 0.02 41.25 DUODENITIS | 4 0.04 41.29 DYSAESTHESIA | 1 0.01 41.30 DYSLIPIDAEMIA | 8 0.08 41.38 DYSMENORRHOEA | 2 0.02 41.40 DYSPEPSIA | 11 0.11 41.51 DYSPHAGIA | 1 0.01 41.52 DYSPHEMIA | 2 0.02 41.54 DYSPNOEA | 5 0.05 41.59 DYSTONIA | 1 0.01 41.60 EAR INFECTION | 3 0.03 41.63 ECHOCARDIOGRAM | 2 0.02 41.65 ECZEMA | 1 0.01 41.66 ELECTROLYTE SUBSTITUTION THERAPY | 2 0.02 41.68 EMBOLISM | 1 0.01 41.69 EMPHYSEMA | 8 0.08 41.77 EMPYEMA | 6 0.06 41.83 ENCEPHALOPATHY | 1 0.01 41.84 ENDOMETRIAL CANCER | 3 0.03 41.87 ENDOMETRIAL CANCER RECURRENT | 1 0.01 41.88 ENDOMETRIOSIS | 3 0.03 41.91 ENERGY INCREASED | 4 0.04 41.95 ENTEROBACTER INFECTION | 3 0.03 41.98 ENTEROCOCCAL BACTERAEMIA | 1 0.01 41.99 ENTEROCOCCAL INFECTION | 2 0.02 42.01 ENTEROCOLITIS | 3 0.03 42.04 EPIDURAL ANAESTHESIA | 1 0.01 42.05 EPIGLOTTIC CARCINOMA | 3 0.03 42.08 EPILEPSY | 59 0.59 42.67 EPISTAXIS | 1 0.01 42.68 ERECTILE DYSFUNCTION | 15 0.15 42.83 ERYSIPELAS | 1 0.01 42.84 ESCHERICHIA INFECTION | 2 0.02 42.86 ESSENTIAL HYPERTENSION | 22 0.22 43.08 EWING'S SARCOMA | 5 0.05 43.13 EX-SMOKER | 18 0.18 43.31 EXERCISE ELECTROCARDIOGRAM ABNORMAL | 1 0.01 43.32 EXTRAPYRAMIDAL DISORDER | 2 0.02 43.34 EYE DEGENERATIVE DISORDER | 1 0.01 43.35 FABRY'S DISEASE | 3 0.03 43.38 FACIAL PAIN | 2 0.02 43.40 FACTOR IX DEFICIENCY | 1 0.01 43.41 FACTOR VIII DEFICIENCY | 1 0.01 43.42 FATIGUE | 3 0.03 43.45 FEBRILE NEUTROPENIA | 2 0.02 43.47 FEELING OF RELAXATION | 1 0.01 43.48 FIBROMYALGIA | 6 0.06 43.54 FLATULENCE | 2 0.02 43.56 FLUID RETENTION | 1 0.01 43.57 FOETAL DISTRESS SYNDROME | 3 0.03 43.60 FOLATE DEFICIENCY | 3 0.03 43.63 FOLLICULITIS | 1 0.01 43.64 FUNGAL INFECTION | 3 0.03 43.67 FUNGAL SEPSIS | 2 0.02 43.69 FUNGAL SKIN INFECTION | 2 0.02 43.71 FUSARIUM INFECTION | 1 0.01 43.72 GASTRIC CANCER | 19 0.19 43.91 GASTRIC DISORDER | 3 0.03 43.94 GASTRIC ULCER | 7 0.07 44.01 GASTRITIS | 34 0.34 44.35 GASTRITIS PROPHYLAXIS | 2 0.02 44.37 GASTROENTERITIS | 6 0.06 44.43 GASTROINTESTINAL CANDIDIASIS | 1 0.01 44.44 GASTROINTESTINAL CARCINOMA | 1 0.01 44.45 GASTROINTESTINAL DISORDER | 7 0.07 44.52 GASTROINTESTINAL DISORDER THERAPY | 2 0.02 44.54 GASTROINTESTINAL HAEMORRHAGE | 2 0.02 44.56 GASTROINTESTINAL MOTILITY DISORDER | 1 0.01 44.57 GASTROINTESTINAL MUCOSAL DISORDER | 1 0.01 44.58 GASTROINTESTINAL PAIN | 1 0.01 44.59 GASTROINTESTINAL STROMAL TUMOUR | 13 0.13 44.72 GASTROOESOPHAGEAL REFLUX DISEASE | 36 0.36 45.08 GENERAL ANAESTHESIA | 2 0.02 45.10 GENERAL PHYSICAL CONDITION | 12 0.12 45.22 GENERALISED ANXIETY DISORDER | 4 0.04 45.26 GINGIVAL INFECTION | 1 0.01 45.27 GLAUCOMA | 18 0.18 45.45 GLIOBLASTOMA | 4 0.04 45.49 GLIOBLASTOMA MULTIFORME | 5 0.05 45.54 GLIOMA | 17 0.17 45.71 GLOBAL AMNESIA | 1 0.01 45.72 GLOMERULONEPHRITIS | 1 0.01 45.73 GLOSSITIS | 1 0.01 45.74 GLYCOGEN STORAGE DISEASE TYPE II | 1 0.01 45.75 GOUT | 10 0.10 45.85 GRAFT VERSUS HOST DISEASE | 2 0.02 45.87 GRAND MAL CONVULSION | 5 0.05 45.92 GROWTH HORMONE DEFICIENCY | 8 0.08 46.00 HAEMATOCRIT DECREASED | 1 0.01 46.01 HAEMODYNAMIC INSTABILITY | 2 0.02 46.03 HAEMOGLOBIN DECREASED | 1 0.01 46.04 HAEMOPHILIA B WITH ANTI FACTOR IX | 1 0.01 46.05 HAEMOPHILUS INFECTION | 2 0.02 46.07 HAEMOPTYSIS | 1 0.01 46.08 HAEMORRHAGE | 4 0.04 46.12 HAIR GROWTH ABNORMAL | 1 0.01 46.13 HAIRY CELL LEUKAEMIA | 2 0.02 46.15 HALLUCINATION | 3 0.03 46.18 HALLUCINATION, AUDITORY | 3 0.03 46.21 HANGOVER | 1 0.01 46.22 HEAD DISCOMFORT | 1 0.01 46.23 HEAD INJURY | 4 0.04 46.27 HEADACHE | 21 0.21 46.48 HEART AND LUNG TRANSPLANT | 1 0.01 46.49 HEART RATE | 1 0.01 46.50 HEART RATE IRREGULAR | 1 0.01 46.51 HEART TRANSPLANT | 2 0.02 46.53 HEMIPARESIS | 1 0.01 46.54 HEMIPLEGIA | 2 0.02 46.56 HEPARIN-INDUCED THROMBOCYTOPENIA | 2 0.02 46.58 HEPATIC ARTERY THROMBOSIS | 1 0.01 46.59 HEPATIC CANCER METASTATIC | 1 0.01 46.60 HEPATIC CIRRHOSIS | 3 0.03 46.63 HEPATIC CYST | 1 0.01 46.64 HEPATIC FAILURE | 1 0.01 46.65 HEPATIC LESION | 1 0.01 46.66 HEPATIC NEOPLASM MALIGNANT | 11 0.11 46.77 HEPATITIS B | 16 0.16 46.93 HEPATITIS C | 82 0.82 47.75 HEPATOBILIARY SCAN | 2 0.02 47.77 HERPES SIMPLEX | 2 0.02 47.79 HERPES VIRUS INFECTION | 1 0.01 47.80 HERPES ZOSTER | 16 0.16 47.96 HIATUS HERNIA | 4 0.04 48.00 HISTIOCYTOSIS HAEMATOPHAGIC | 8 0.08 48.08 HIV INFECTION | 460 4.60 52.68 HIV TEST POSITIVE | 6 0.06 52.74 HODGKIN'S DISEASE | 9 0.09 52.83 HODGKIN'S DISEASE RECURRENT | 2 0.02 52.85 HORMONE LEVEL ABNORMAL | 1 0.01 52.86 HORMONE REPLACEMENT THERAPY | 29 0.29 53.15 HORMONE SUPPRESSION THERAPY | 3 0.03 53.18 HORMONE THERAPY | 1 0.01 53.19 HOT FLUSH | 1 0.01 53.20 HYPERCALCAEMIA | 1 0.01 53.21 HYPERCHLORHYDRIA | 1 0.01 53.22 HYPERCHOLESTEROLAEMIA | 56 0.56 53.78 HYPERGLYCAEMIA | 3 0.03 53.81 HYPERHIDROSIS | 3 0.03 53.84 HYPERKALAEMIA | 1 0.01 53.85 HYPERKERATOSIS | 1 0.01 53.86 HYPERKERATOSIS PALMARIS AND PLANTARIS | 2 0.02 53.88 HYPERLIPIDAEMIA | 47 0.47 54.35 HYPERPARATHYROIDISM | 3 0.03 54.38 HYPERPARATHYROIDISM SECONDARY | 12 0.12 54.50 HYPERPHOSPHATAEMIA | 3 0.03 54.53 HYPERPROLACTINAEMIA | 1 0.01 54.54 HYPERSENSITIVITY | 20 0.20 54.74 HYPERSOMNIA | 1 0.01 54.75 HYPERTENSION | 450 4.50 59.25 HYPERTENSIVE CARDIOMYOPATHY | 4 0.04 59.29 HYPERTENSIVE HEART DISEASE | 1 0.01 59.30 HYPERTHYROIDISM | 2 0.02 59.32 HYPERTONIA | 1 0.01 59.33 HYPERTONIC BLADDER | 2 0.02 59.35 HYPERTRIGLYCERIDAEMIA | 1 0.01 59.36 HYPERTROPHIC CARDIOMYOPATHY | 2 0.02 59.38 HYPERURICAEMIA | 9 0.09 59.47 HYPOAESTHESIA | 4 0.04 59.51 HYPOALBUMINAEMIA | 1 0.01 59.52 HYPOGAMMAGLOBULINAEMIA | 3 0.03 59.55 HYPOKALAEMIA | 2 0.02 59.57 HYPONATRAEMIA | 1 0.01 59.58 HYPOPITUITARISM | 4 0.04 59.62 HYPOTENSION | 1 0.01 59.63 HYPOTHYROIDISM | 27 0.27 59.90 HYSTERECTOMY | 1 0.01 59.91 IATROGENIC INFECTION | 1 0.01 59.92 IDIOPATHIC PULMONARY FIBROSIS | 1 0.01 59.93 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 3 0.03 59.96 ILEUS | 1 0.01 59.97 ILL-DEFINED DISORDER | 35 0.35 60.32 IMMUNE ENHANCEMENT THERAPY | 1 0.01 60.33 IMMUNE RECONSTITUTION SYNDROME | 2 0.02 60.35 IMMUNODEFICIENCY CONGENITAL | 1 0.01 60.36 IMMUNOSUPPRESSANT DRUG THERAPY | 4 0.04 60.40 IMMUNOSUPPRESSION | 8 0.08 60.48 IMPAIRED GASTRIC EMPTYING | 2 0.02 60.50 IMPAIRED HEALING | 1 0.01 60.51 IMPULSIVE BEHAVIOUR | 2 0.02 60.53 INCONTINENCE | 3 0.03 60.56 INDUCED LABOUR | 3 0.03 60.59 INDUCTION AND MAINTENANCE OF ANAESTHE.. | 1 0.01 60.60 INDUCTION OF ANAESTHESIA | 1 0.01 60.61 INFECTION | 10 0.10 60.71 INFECTION PROPHYLAXIS | 11 0.11 60.82 INFILTRATION ANAESTHESIA | 1 0.01 60.83 INFLAMMATION | 4 0.04 60.87 INFLAMMATORY CARCINOMA OF BREAST STAG.. | 1 0.01 60.88 INFLAMMATORY CARCINOMA OF THE BREAST | 2 0.02 60.90 INFLUENZA | 62 0.62 61.52 INFLUENZA LIKE ILLNESS | 2 0.02 61.54 INJECTION | 1 0.01 61.55 INJECTION SITE PAIN | 1 0.01 61.56 INJECTION SITE REACTION | 2 0.02 61.58 INSOMNIA | 103 1.03 62.61 INSULIN-REQUIRING TYPE II DIABETES ME.. | 8 0.08 62.69 INTENTIONAL DRUG MISUSE | 1 0.01 62.70 INTERSTITIAL LUNG DISEASE | 1 0.01 62.71 INTERVERTEBRAL DISC DEGENERATION | 6 0.06 62.77 INTERVERTEBRAL DISC PROTRUSION | 6 0.06 62.83 INTRA-CEREBRAL ANEURYSM OPERATION | 1 0.01 62.84 INTRAOCULAR PRESSURE INCREASED | 2 0.02 62.86 INTRAOCULAR PRESSURE TEST | 1 0.01 62.87 IRITIS | 2 0.02 62.89 IRON DEFICIENCY | 1 0.01 62.90 IRON DEFICIENCY ANAEMIA | 2 0.02 62.92 IRON OVERLOAD | 8 0.08 63.00 IRRITABILITY | 1 0.01 63.01 IRRITABLE BOWEL SYNDROME | 21 0.21 63.22 ISCHAEMIC CARDIOMYOPATHY | 2 0.02 63.24 ISCHAEMIC STROKE | 2 0.02 63.26 JOINT INJURY | 2 0.02 63.28 JUVENILE ARTHRITIS | 20 0.20 63.48 KAPOSI'S SARCOMA | 3 0.03 63.51 KAWASAKI'S DISEASE | 5 0.05 63.56 KERATITIS | 2 0.02 63.58 KIDNEY TRANSPLANT REJECTION | 1 0.01 63.59 KLEBSIELLA BACTERAEMIA | 1 0.01 63.60 LAXATIVE SUPPORTIVE CARE | 2 0.02 63.62 LEARNING DISORDER | 1 0.01 63.63 LEUKAEMIA | 3 0.03 63.66 LIBIDO DECREASED | 2 0.02 63.68 LIGAMENT RUPTURE | 1 0.01 63.69 LIMB INJURY | 2 0.02 63.71 LIP AND/OR ORAL CAVITY CANCER | 1 0.01 63.72 LIPIDS | 2 0.02 63.74 LIPIDS INCREASED | 2 0.02 63.76 LIVER DISORDER | 1 0.01 63.77 LIVER TRANSPLANT | 14 0.14 63.91 LOCAL ANAESTHESIA | 1 0.01 63.92 LOCALISED INFECTION | 1 0.01 63.93 LOW CARDIAC OUTPUT SYNDROME | 1 0.01 63.94 LOW DENSITY LIPOPROTEIN INCREASED | 1 0.01 63.95 LOWER RESPIRATORY TRACT INFECTION | 1 0.01 63.96 LUMBAR RADICULOPATHY | 1 0.01 63.97 LUMBAR SPINAL STENOSIS | 1 0.01 63.98 LUNG ADENOCARCINOMA | 7 0.07 64.05 LUNG ADENOCARCINOMA METASTATIC | 2 0.02 64.07 LUNG ADENOCARCINOMA STAGE III | 1 0.01 64.08 LUNG CANCER METASTATIC | 3 0.03 64.11 LUNG DISORDER | 7 0.07 64.18 LUNG INFECTION | 6 0.06 64.24 LUNG NEOPLASM MALIGNANT | 19 0.19 64.43 LUNG SQUAMOUS CELL CARCINOMA STAGE II | 1 0.01 64.44 LUNG TRANSPLANT | 3 0.03 64.47 LYMPHANGIOSIS CARCINOMATOSA | 2 0.02 64.49 LYMPHOMA | 6 0.06 64.55 MACROANGIOPATHY | 1 0.01 64.56 MACULAR DEGENERATION | 11 0.11 64.67 MAINTENANCE OF ANAESTHESIA | 5 0.05 64.72 MAJOR DEPRESSION | 10 0.10 64.82 MALARIA PROPHYLAXIS | 7 0.07 64.89 MALE PATTERN BALDNESS | 4 0.04 64.93 MALIGNANT GLIOMA | 1 0.01 64.94 MALIGNANT HYPERTENSION | 1 0.01 64.95 MALIGNANT MELANOMA | 11 0.11 65.06 MALIGNANT NEOPLASM OF RENAL PELVIS | 2 0.02 65.08 MALIGNANT NEOPLASM PROGRESSION | 4 0.04 65.12 MALNUTRITION | 2 0.02 65.14 MANIA | 7 0.07 65.21 MANTLE CELL LYMPHOMA | 1 0.01 65.22 MEDICAL DIET | 3 0.03 65.25 MEDICATION DILUTION | 1 0.01 65.26 MEDULLOBLASTOMA | 1 0.01 65.27 MEMORY IMPAIRMENT | 1 0.01 65.28 MENIERE'S DISEASE | 1 0.01 65.29 MENINGITIS | 1 0.01 65.30 MENINGOCOCCAL INFECTION | 1 0.01 65.31 MENOMETRORRHAGIA | 1 0.01 65.32 MENOPAUSAL SYMPTOMS | 22 0.22 65.54 MENOPAUSE | 15 0.15 65.69 MENORRHAGIA | 4 0.04 65.73 MENSTRUAL DISORDER | 1 0.01 65.74 MENSTRUATION IRREGULAR | 2 0.02 65.76 MENTAL DISORDER | 10 0.10 65.86 METASTASES TO BONE | 40 0.40 66.26 METASTASES TO LUNG | 2 0.02 66.28 METASTASES TO PLEURA | 2 0.02 66.30 METASTASIS | 1 0.01 66.31 METASTATIC GASTRIC CANCER | 2 0.02 66.33 METASTATIC MALIGNANT MELANOMA | 4 0.04 66.37 METASTATIC NEOPLASM | 4 0.04 66.41 METASTATIC RENAL CELL CARCINOMA | 26 0.26 66.67 METASTATIC SQUAMOUS CELL CARCINOMA | 1 0.01 66.68 MIDDLE INSOMNIA | 1 0.01 66.69 MIGRAINE | 29 0.29 66.98 MIGRAINE PROPHYLAXIS | 6 0.06 67.04 MINERAL SUPPLEMENTATION | 6 0.06 67.10 MITRAL VALVE INCOMPETENCE | 1 0.01 67.11 MONARTHRITIS | 1 0.01 67.12 MOOD ALTERED | 3 0.03 67.15 MOOD SWINGS | 1 0.01 67.16 MOTION SICKNESS | 2 0.02 67.18 MOTOR NEURONE DISEASE | 1 0.01 67.19 MUCOSAL INFLAMMATION | 6 0.06 67.25 MULTIPLE ALLERGIES | 6 0.06 67.31 MULTIPLE MYELOMA | 58 0.58 67.89 MULTIPLE SCLEROSIS | 74 0.74 68.63 MULTIPLE SCLEROSIS RELAPSE | 3 0.03 68.66 MUSCLE RELAXANT THERAPY | 4 0.04 68.70 MUSCLE RIGIDITY | 1 0.01 68.71 MUSCLE SPASMS | 12 0.12 68.83 MUSCLE SPASTICITY | 8 0.08 68.91 MUSCLE STRAIN | 1 0.01 68.92 MUSCULAR DYSTROPHY | 1 0.01 68.93 MUSCULOSKELETAL PAIN | 8 0.08 69.01 MUSCULOSKELETAL STIFFNESS | 2 0.02 69.03 MYALGIA | 9 0.09 69.12 MYASTHENIA GRAVIS | 8 0.08 69.20 MYCOBACTERIUM ABSCESSUS INFECTION | 1 0.01 69.21 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 25 0.25 69.46 MYCOSIS FUNGOIDES REFRACTORY | 1 0.01 69.47 MYELODYSPLASTIC SYNDROME | 13 0.13 69.60 MYELOFIBROSIS | 8 0.08 69.68 MYOCARDIAL INFARCTION | 15 0.15 69.83 MYOCARDIAL ISCHAEMIA | 12 0.12 69.95 MYOFASCIAL PAIN SYNDROME | 1 0.01 69.96 MYOPIA | 1 0.01 69.97 MYRINGOPLASTY | 4 0.04 70.01 NAIL TINEA | 7 0.07 70.08 NARCOLEPSY | 6 0.06 70.14 NASAL CONGESTION | 3 0.03 70.17 NASAL DRYNESS | 1 0.01 70.18 NASAL OPERATION | 1 0.01 70.19 NASAL ULCER | 1 0.01 70.20 NASOPHARYNGITIS | 7 0.07 70.27 NAUSEA | 30 0.30 70.57 NECK INJURY | 2 0.02 70.59 NECK PAIN | 8 0.08 70.67 NEOPLASM MALIGNANT | 17 0.17 70.84 NEPHROGENIC ANAEMIA | 1 0.01 70.85 NEPHROLITHIASIS | 1 0.01 70.86 NEPHROSCLEROSIS | 2 0.02 70.88 NEPHROTIC SYNDROME | 2 0.02 70.90 NERVE COMPRESSION | 1 0.01 70.91 NERVE INJURY | 4 0.04 70.95 NERVOUSNESS | 2 0.02 70.97 NEURALGIA | 34 0.34 71.31 NEURODEGENERATIVE DISORDER | 1 0.01 71.32 NEUROFIBROMATOSIS | 1 0.01 71.33 NEUROGENIC BLADDER | 1 0.01 71.34 NEUROPATHY | 10 0.10 71.44 NEUROPATHY PERIPHERAL | 10 0.10 71.54 NEUTROPENIA | 7 0.07 71.61 NIGHTMARE | 2 0.02 71.63 NOCARDIOSIS | 3 0.03 71.66 NODAL ARRHYTHMIA | 1 0.01 71.67 NON-HODGKIN'S LYMPHOMA | 73 0.73 72.40 NON-SMALL CELL LUNG CANCER | 132 1.32 73.72 NON-SMALL CELL LUNG CANCER METASTATIC | 1 0.01 73.73 NON-SMALL CELL LUNG CANCER STAGE IV | 3 0.03 73.76 NUCLEAR MAGNETIC RESONANCE IMAGING | 3 0.03 73.79 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 1 0.01 73.80 NUTRITIONAL SUPPORT | 8 0.08 73.88 OBESITY | 12 0.12 74.00 OBSESSIVE-COMPULSIVE DISORDER | 3 0.03 74.03 OBSTRUCTIVE CHRONIC BRONCHITIS WITH A.. | 1 0.01 74.04 OCULAR HYPERTENSION | 1 0.01 74.05 OEDEMA | 7 0.07 74.12 OEDEMA PERIPHERAL | 3 0.03 74.15 OESOPHAGEAL CANDIDIASIS | 7 0.07 74.22 OESOPHAGEAL CARCINOMA | 5 0.05 74.27 OESOPHAGITIS | 1 0.01 74.28 OLIGODENDROGLIOMA | 1 0.01 74.29 OLIGURIA | 1 0.01 74.30 ONYCHOMYCOSIS | 2 0.02 74.32 OPPORTUNISTIC INFECTION PROPHYLAXIS | 5 0.05 74.37 OPPOSITIONAL DEFIANT DISORDER | 3 0.03 74.40 ORAL CANDIDIASIS | 4 0.04 74.44 ORAL CONTRACEPTION | 9 0.09 74.53 ORTHOSTATIC HYPOTENSION | 1 0.01 74.54 OSTEITIS | 1 0.01 74.55 OSTEITIS DEFORMANS | 1 0.01 74.56 OSTEOARTHRITIS | 32 0.32 74.88 OSTEOLYSIS | 2 0.02 74.90 OSTEOMYELITIS | 6 0.06 74.96 OSTEONECROSIS | 1 0.01 74.97 OSTEOPENIA | 16 0.16 75.13 OSTEOPOROSIS | 138 1.38 76.51 OSTEOPOROSIS POSTMENOPAUSAL | 3 0.03 76.54 OSTEOSARCOMA METASTATIC | 3 0.03 76.57 OTITIS MEDIA ACUTE | 1 0.01 76.58 OTITIS MEDIA CHRONIC | 1 0.01 76.59 OVARIAN CANCER | 12 0.12 76.71 OVARIAN EPITHELIAL CANCER RECURRENT | 1 0.01 76.72 OVERWEIGHT | 1 0.01 76.73 PAIN | 203 2.03 78.76 PAIN IN EXTREMITY | 15 0.15 78.91 PAIN IN JAW | 2 0.02 78.93 PAIN MANAGEMENT | 21 0.21 79.14 PAIN PROPHYLAXIS | 1 0.01 79.15 PALLIATIVE CARE | 2 0.02 79.17 PANCREATIC CARCINOMA | 14 0.14 79.31 PANCREATIC CARCINOMA METASTATIC | 1 0.01 79.32 PANCREATIC INSUFFICIENCY | 2 0.02 79.34 PANCREATITIS ACUTE | 1 0.01 79.35 PANCYTOPENIA | 1 0.01 79.36 PANIC ATTACK | 10 0.10 79.46 PANIC DISORDER | 6 0.06 79.52 PANIC REACTION | 1 0.01 79.53 PARAESTHESIA | 2 0.02 79.55 PARANOIA | 1 0.01 79.56 PARKINSON'S DISEASE | 44 0.44 80.00 PARKINSONISM | 2 0.02 80.02 PARTIAL SEIZURES | 5 0.05 80.07 PATENT DUCTUS ARTERIOSUS | 3 0.03 80.10 PELVIC PAIN | 3 0.03 80.13 PENIS DISORDER | 1 0.01 80.14 PEPTIC ULCER | 1 0.01 80.15 PERCUTANEOUS CORONARY INTERVENTION | 2 0.02 80.17 PERICARDIAL EFFUSION | 1 0.01 80.18 PERIODONTAL DISEASE | 1 0.01 80.19 PERIODONTAL OPERATION | 1 0.01 80.20 PERIODONTITIS | 1 0.01 80.21 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 1 0.01 80.22 PERIPHERAL BLOOD STEM CELL APHERESIS | 1 0.01 80.23 PERITONEAL DIALYSIS | 30 0.30 80.53 PERITONITIS | 1 0.01 80.54 PERSECUTORY DELUSION | 2 0.02 80.56 PERSONALITY DISORDER | 1 0.01 80.57 PETIT MAL EPILEPSY | 2 0.02 80.59 PHANTOM PAIN | 1 0.01 80.60 PHARYNGITIS | 10 0.10 80.70 PHARYNGOLARYNGEAL PAIN | 2 0.02 80.72 PHLEBITIS | 3 0.03 80.75 PHOBIA | 1 0.01 80.76 PITUITARY TUMOUR BENIGN | 4 0.04 80.80 PLEURAL EFFUSION | 2 0.02 80.82 PLEURAL MESOTHELIOMA MALIGNANT | 5 0.05 80.87 PNEUMOCYSTIS JIROVECI INFECTION | 3 0.03 80.90 PNEUMOCYSTIS JIROVECI PNEUMONIA | 1 0.01 80.91 PNEUMONIA | 32 0.32 81.23 PNEUMONIA BACTERIAL | 3 0.03 81.26 PNEUMONIA FUNGAL | 1 0.01 81.27 POLLAKIURIA | 6 0.06 81.33 POLYARTHRITIS | 14 0.14 81.47 POLYCYSTIC OVARIES | 1 0.01 81.48 POLYCYTHAEMIA VERA | 1 0.01 81.49 POLYMYALGIA RHEUMATICA | 3 0.03 81.52 POLYURIA | 1 0.01 81.53 POOR PERIPHERAL CIRCULATION | 3 0.03 81.56 POST HERPETIC NEURALGIA | 9 0.09 81.65 POST PROCEDURAL COMPLICATION | 1 0.01 81.66 POST PROCEDURAL INFECTION | 1 0.01 81.67 POST-TRAUMATIC STRESS DISORDER | 6 0.06 81.73 POSTMENOPAUSE | 1 0.01 81.74 POSTNASAL DRIP | 3 0.03 81.77 POSTOPERATIVE ANALGESIA | 3 0.03 81.80 POSTOPERATIVE CARE | 1 0.01 81.81 POSTPARTUM DEPRESSION | 4 0.04 81.85 PRADER-WILLI SYNDROME | 1 0.01 81.86 PRE-EXISTING DISEASE | 2 0.02 81.88 PRECOCIOUS PUBERTY | 1 0.01 81.89 PREGNANCY | 2 0.02 81.91 PREMATURE LABOUR | 1 0.01 81.92 PREMEDICATION | 58 0.58 82.50 PRENATAL CARE | 2 0.02 82.52 PREOPERATIVE CARE | 1 0.01 82.53 PROCEDURAL HYPOTENSION | 1 0.01 82.54 PROCEDURAL NAUSEA | 1 0.01 82.55 PROCEDURAL PAIN | 2 0.02 82.57 PROGRESSIVE MULTIPLE SCLEROSIS | 1 0.01 82.58 PROLACTINOMA | 4 0.04 82.62 PROMOTION OF PERIPHERAL CIRCULATION | 1 0.01 82.63 PROPHYLACTIC CHEMOTHERAPY | 3 0.03 82.66 PROPHYLAXIS | 147 1.47 84.13 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 10 0.10 84.23 PROPHYLAXIS AGAINST GRAFT VERSUS HOST.. | 2 0.02 84.25 PROPHYLAXIS AGAINST HIV INFECTION | 11 0.11 84.36 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 35 0.35 84.71 PROPHYLAXIS OF NAUSEA AND VOMITING | 13 0.13 84.84 PROSTATE CANCER | 20 0.20 85.04 PROSTATE CANCER METASTATIC | 2 0.02 85.06 PROSTATE CANCER STAGE I | 1 0.01 85.07 PROSTATE EXAMINATION ABNORMAL | 5 0.05 85.12 PROSTATIC DISORDER | 1 0.01 85.13 PROSTATISM | 2 0.02 85.15 PROSTATITIS | 5 0.05 85.20 PROTEINURIA | 1 0.01 85.21 PRURITUS | 3 0.03 85.24 PRURITUS GENITAL | 1 0.01 85.25 PSEUDOMONAS INFECTION | 2 0.02 85.27 PSORIASIS | 35 0.35 85.62 PSORIATIC ARTHROPATHY | 35 0.35 85.97 PSYCHOMOTOR HYPERACTIVITY | 1 0.01 85.98 PSYCHOTIC DISORDER | 17 0.17 86.15 PSYCHOTIC DISORDER DUE TO A GENERAL M.. | 5 0.05 86.20 PULMONARY EMBOLISM | 3 0.03 86.23 PULMONARY FIBROSIS | 1 0.01 86.24 PULMONARY HYPERTENSION | 16 0.16 86.40 PULMONARY OEDEMA | 1 0.01 86.41 PUNCTATE KERATITIS | 1 0.01 86.42 PUSTULAR PSORIASIS | 4 0.04 86.46 PYREXIA | 26 0.26 86.72 RADICULAR PAIN | 1 0.01 86.73 RADICULOPATHY | 2 0.02 86.75 RADIOTHERAPY | 1 0.01 86.76 RADIOTHERAPY TO BREAST | 1 0.01 86.77 RASH | 2 0.02 86.79 RECTAL CANCER | 13 0.13 86.92 RECURRENT CANCER | 1 0.01 86.93 REFLUX OESOPHAGITIS | 13 0.13 87.06 REFRACTORY ANAEMIA | 2 0.02 87.08 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 13 0.13 87.21 RENAL AND PANCREAS TRANSPLANT | 1 0.01 87.22 RENAL CANCER METASTATIC | 4 0.04 87.26 RENAL CELL CARCINOMA STAGE IV | 1 0.01 87.27 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 33 0.33 87.60 RENAL DISORDER | 6 0.06 87.66 RENAL FAILURE | 10 0.10 87.76 RENAL FAILURE CHRONIC | 17 0.17 87.93 RENAL HYPERTENSION | 1 0.01 87.94 RENAL NEOPLASM | 3 0.03 87.97 RENAL TRANSPLANT | 37 0.37 88.34 RESPIRATORY DISORDER | 3 0.03 88.37 RESPIRATORY TRACT INFECTION | 3 0.03 88.40 RESTLESS LEGS SYNDROME | 9 0.09 88.49 RESTLESSNESS | 1 0.01 88.50 RETINAL ARTERY OCCLUSION | 3 0.03 88.53 RETINAL OEDEMA | 1 0.01 88.54 RETINAL VEIN THROMBOSIS | 1 0.01 88.55 REVERSAL OF SEDATION | 1 0.01 88.56 RHABDOMYOSARCOMA | 3 0.03 88.59 RHEUMATOID ARTHRITIS | 352 3.52 92.11 RHINITIS | 3 0.03 92.14 RHINITIS ALLERGIC | 3 0.03 92.17 ROAD TRAFFIC ACCIDENT | 1 0.01 92.18 ROTATOR CUFF SYNDROME | 1 0.01 92.19 ROUTINE HEALTH MAINTENANCE | 2 0.02 92.21 SARCOIDOSIS | 6 0.06 92.27 SARCOMA | 3 0.03 92.30 SARCOMA UTERUS | 1 0.01 92.31 SCHIZOAFFECTIVE DISORDER | 12 0.12 92.43 SCHIZOPHRENIA | 110 1.10 93.53 SCHIZOPHRENIA SIMPLE | 2 0.02 93.55 SCHIZOPHRENIA, PARANOID TYPE | 13 0.13 93.68 SCHIZOTYPAL PERSONALITY DISORDER | 1 0.01 93.69 SCIATIC NERVE INJURY | 1 0.01 93.70 SCIATICA | 6 0.06 93.76 SCINTIGRAPHY | 2 0.02 93.78 SCLERODERMA | 3 0.03 93.81 SEASONAL AFFECTIVE DISORDER | 1 0.01 93.82 SEASONAL ALLERGY | 6 0.06 93.88 SEBORRHOEIC DERMATITIS | 4 0.04 93.92 SECONDARY PROGRESSIVE MULTIPLE SCLERO.. | 3 0.03 93.95 SEDATION | 9 0.09 94.04 SEDATIVE THERAPY | 1 0.01 94.05 SEIZURE ANOXIC | 1 0.01 94.06 SENILE DEMENTIA | 1 0.01 94.07 SENSITIVITY OF TEETH | 1 0.01 94.08 SENSORY DISTURBANCE | 1 0.01 94.09 SEPSIS | 26 0.26 94.35 SEPTIC SHOCK | 6 0.06 94.41 SEXUAL DYSFUNCTION | 1 0.01 94.42 SHUNT INFECTION | 1 0.01 94.43 SICKLE CELL ANAEMIA | 3 0.03 94.46 SINOBRONCHITIS | 4 0.04 94.50 SINUS DISORDER | 3 0.03 94.53 SINUS TACHYCARDIA | 1 0.01 94.54 SINUSITIS | 23 0.23 94.77 SKIN DISCOLOURATION | 1 0.01 94.78 SKIN DISORDER | 1 0.01 94.79 SKIN INFECTION | 1 0.01 94.80 SKIN LACERATION | 1 0.01 94.81 SKIN WRINKLING | 3 0.03 94.84 SLEEP APNOEA SYNDROME | 6 0.06 94.90 SLEEP DISORDER | 52 0.52 95.42 SLEEP DISORDER THERAPY | 2 0.02 95.44 SLEEP WALKING | 1 0.01 95.45 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 20 0.20 95.65 SMOKER | 1 0.01 95.66 SMOKING CESSATION THERAPY | 48 0.48 96.14 SOCIAL PHOBIA | 1 0.01 96.15 SOMATISATION DISORDER | 1 0.01 96.16 SOMNOLENCE | 5 0.05 96.21 SPINAL ANAESTHESIA | 1 0.01 96.22 SPINAL COLUMN STENOSIS | 2 0.02 96.24 SPINAL CORD COMPRESSION | 1 0.01 96.25 SPINAL CORD INJURY | 1 0.01 96.26 SPINAL DISORDER | 1 0.01 96.27 SPONDYLOARTHROPATHY | 1 0.01 96.28 SPUTUM PURULENT | 1 0.01 96.29 SQUAMOUS CELL CARCINOMA | 3 0.03 96.32 SQUAMOUS CELL CARCINOMA OF THE CERVIX | 1 0.01 96.33 STAPHYLOCOCCAL BACTERAEMIA | 1 0.01 96.34 STAPHYLOCOCCAL INFECTION | 5 0.05 96.39 STAPHYLOCOCCAL SEPSIS | 1 0.01 96.40 STEM CELL TRANSPLANT | 3 0.03 96.43 STENT PLACEMENT | 9 0.09 96.52 STOMACH DISCOMFORT | 3 0.03 96.55 STOMATITIS | 7 0.07 96.62 STREPTOCOCCAL INFECTION | 1 0.01 96.63 STRESS | 2 0.02 96.65 STRESS ECHOCARDIOGRAM | 2 0.02 96.67 STRESS URINARY INCONTINENCE | 1 0.01 96.68 STRUCK BY LIGHTNING | 2 0.02 96.70 SUBCUTANEOUS ABSCESS | 1 0.01 96.71 SUICIDE ATTEMPT | 8 0.08 96.79 SUPERIOR VENA CAVAL OCCLUSION | 1 0.01 96.80 SUPPLEMENTATION THERAPY | 5 0.05 96.85 SUPPRESSED LACTATION | 1 0.01 96.86 SURGERY | 6 0.06 96.92 SWELLING | 1 0.01 96.93 SYNOVITIS | 1 0.01 96.94 SYSTEMIC ANTIVIRAL TREATMENT | 7 0.07 97.01 SYSTEMIC LUPUS ERYTHEMATOSUS | 6 0.06 97.07 T-CELL LYMPHOMA | 29 0.29 97.36 TACHYCARDIA | 6 0.06 97.42 TACHYCARDIA PAROXYSMAL | 2 0.02 97.44 TELANGIECTASIA CONGENITAL | 1 0.01 97.45 TEMPORAL ARTERITIS | 1 0.01 97.46 TEMPORAL LOBE EPILEPSY | 2 0.02 97.48 TENDON RUPTURE | 1 0.01 97.49 TENOSYNOVITIS | 1 0.01 97.50 TENSION | 2 0.02 97.52 TESTICULAR CANCER METASTATIC | 3 0.03 97.55 TESTICULAR GERM CELL CANCER | 29 0.29 97.84 TESTICULAR SEMINOMA (PURE) | 1 0.01 97.85 THALASSAEMIA | 1 0.01 97.86 THERAPEUTIC SKIN CARE TOPICAL | 1 0.01 97.87 THIRST | 1 0.01 97.88 THROMBOCYTOPENIA | 2 0.02 97.90 THROMBOSIS | 2 0.02 97.92 THROMBOSIS PROPHYLAXIS | 21 0.21 98.13 THYROID DISORDER | 8 0.08 98.21 THYROID NEOPLASM | 1 0.01 98.22 THYROIDITIS | 3 0.03 98.25 TOBACCO WITHDRAWAL SYMPTOMS | 1 0.01 98.26 TONGUE CANCER METASTATIC | 1 0.01 98.27 TONSILLITIS | 1 0.01 98.28 TOOTH ABSCESS | 1 0.01 98.29 TOOTH DISCOLOURATION | 1 0.01 98.30 TOOTH DISORDER | 1 0.01 98.31 TOOTH EXTRACTION | 1 0.01 98.32 TOOTHACHE | 1 0.01 98.33 TOXOPLASMOSIS | 4 0.04 98.37 TOXOPLASMOSIS PROPHYLAXIS | 4 0.04 98.41 TRANSFUSION | 4 0.04 98.45 TRANSIENT ISCHAEMIC ATTACK | 4 0.04 98.49 TRANSITIONAL CELL CARCINOMA | 1 0.01 98.50 TRANSMISSION OF DRUG VIA SEMEN | 1 0.01 98.51 TRANSPLANT | 4 0.04 98.55 TRANSPLANT REJECTION | 2 0.02 98.57 TRANSURETHRAL PROSTATECTOMY | 1 0.01 98.58 TRAUMATIC BRAIN INJURY | 3 0.03 98.61 TRAUMATIC HAEMORRHAGE | 1 0.01 98.62 TRIGEMINAL NEURALGIA | 1 0.01 98.63 TUBERCULIN TEST | 2 0.02 98.65 TUBERCULOSIS | 12 0.12 98.77 TYPE IIA HYPERLIPIDAEMIA | 1 0.01 98.78 ULCER | 3 0.03 98.81 ULTRASOUND SCAN | 1 0.01 98.82 UNEVALUABLE EVENT | 8 0.08 98.90 UPPER GASTROINTESTINAL HAEMORRHAGE | 2 0.02 98.92 UPPER RESPIRATORY TRACT INFECTION | 5 0.05 98.97 UPPER RESPIRATORY TRACT INFLAMMATION | 2 0.02 98.99 URINARY INCONTINENCE | 4 0.04 99.03 URINARY TRACT INFECTION | 17 0.17 99.20 URINE OUTPUT DECREASED | 2 0.02 99.22 UTERINE CANCER | 7 0.07 99.29 UTERINE HAEMORRHAGE | 1 0.01 99.30 UVEITIS | 2 0.02 99.32 VAGINAL CANDIDIASIS | 2 0.02 99.34 VAGINITIS BACTERIAL | 1 0.01 99.35 VASCULAR BYPASS GRAFT | 4 0.04 99.39 VENA CAVA THROMBOSIS | 1 0.01 99.40 VENOUS THROMBOSIS | 2 0.02 99.42 VENTRICULAR EXTRASYSTOLES | 1 0.01 99.43 VENTRICULAR HYPERTROPHY | 1 0.01 99.44 VENTRICULAR TACHYCARDIA | 2 0.02 99.46 VERTIGO | 2 0.02 99.48 VIRAEMIA | 2 0.02 99.50 VIRAL INFECTION | 2 0.02 99.52 VITAMIN D DEFICIENCY | 2 0.02 99.54 VITAMIN SUPPLEMENTATION | 12 0.12 99.66 VOMITING | 15 0.15 99.81 VULVOVAGINAL DRYNESS | 1 0.01 99.82 VULVOVAGINAL MYCOTIC INFECTION | 1 0.01 99.83 WEGENER'S GRANULOMATOSIS | 1 0.01 99.84 WEIGHT CONTROL | 9 0.09 99.93 WEIGHT DECREASED | 3 0.03 99.96 WHEEZING | 4 0.04 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015